All covid-19 articles – Page 2
-
-
CareersMeet the first deaf, Black woman to earn a Stem doctorate
Amie Fornah Sankoh has persevered from failing primary school in Sierra Leone to gaining a biochemistry PhD in the US
-
OpinionMargaret Faul: ‘Stand for what you think is right’
The pharmaceutical executive on why chemistry clicked for her, and life as a female organic chemist in the drug industry
-
ResearchGlow-in-the-dark proteins offer cheap and fast diagnostic tests
Covid-19 can be detected with the sensitivity of PCR and the ease of lateral flow
-
OpinionSetting drug development speed records
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
-
BusinessPharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
-
OpinionThe end of a long race?
The finishing line of the Covid-19 pandemic may be in sight, but we mustn’t stop running just yet
-
FeatureCan we clean Covid from the air around us?
Nina Notman talks to the experts about what is needed to remove pollutants and even infectious diseases from the air inside our homes, schools and offices
-
NewsFrench inquiry censures lab that promoted hydroxychloroquine to treat Covid
Report raises awkward questions about prominent study on antimalarial conducted in Didier Raoult’s lab
-
OpinionAngela Russell: ‘We have to not be afraid of failing’
The medicinal chemist on thinking like a scientist and knowing where you want to go
-
BusinessProtective treatment for Covid-19 makes minimal impact
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
-
NewsMedical research charities report £260 million shortfall due to pandemic
The impact of Covid-19 on fundraising efforts sees charities slash research support
-
NewsNew questions raised over Sputnik Covid vaccine results point to fraudulent practices
Analysis comparing Sputnik results with five other Covid vaccines finds phase 3 trial outcome is highly improbable
-
OpinionCatalogues of complexity
The tangled web of fine chemicals supply frequently throws up surprises
-
OpinionTeaching-focused staff contribute to REF results too
But are often overlooked in celebrations of research excellence
-
BusinessWhat is the future of Covid-19 pharmaceuticals?
Firms anticipate long-term markets for prevention and treatment
-
FeatureThe human health observatory in our sewers
From tracking disease outbreaks to monitoring drug use, there’s a lot to be learned from the things we flush down the toilet, Katrina Krämer finds
-
NewsUK’s non-profit vaccine manufacturing centre sold off before opening
Pharmaceutical firm Catalent buys government-backed facility near Oxford
-
BusinessModerna sued over Covid-19 vaccine-related patents
Arbutus and Genevant say lipid nanoparticles that protect mRNA infringe six key patents
-
OpinionLiving through Covid-19
Many researchers are now feeling the effects of additional emotional burdens